For Immediate Release
Chicago, IL –June 28, 2019 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Apple (AAPL - Free Report) , Comcast (CMCSA - Free Report) , Morgan Stanley (MS - Free Report) , Micron (MU - Free Report) and Ford (F - Free Report) .
Here are highlights from Thursday’s Analyst Blog:
Top Stock Reports for Apple, Comcast and Morgan Stanley
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Apple, Comcast and Morgan Stanley. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Apple’s shares have outperformed the broader S&P 500 index on a year-to-date basis (+26.6% vs. +14.9%). The Zacks analyst thinks that the recent WWDC event demonstrated the company’s continued focus on boosting the Services business through cutting-edge software.
Apple unveiled a plethora of software updates and also showcased the new Mac Pro and Pro XDR 6K display. The recent acquisition of Drive.ai adds engineering talent that will provide a boost to Apple’s self-driving efforts. Nevertheless, weak iPhone demand, particularly in China and emerging economies, is a headwind. Moreover, the ongoing U.S.-China trade war doesn’t bode well for the company.
Further, legal woes have increased due to lawsuit from customers related to App Store charges. The company has also been accused of unfair practices by Spotify. These are significant headwinds for investors, at least in the near term.
(You can read the full research report on Apple here >>>).
Shares of Outperform-rated Comcast have outperformed the Zacks Cable Television industry in the past year, gaining +29% vs. +21.6%. The Zacks analyst thinks Comcast is benefiting from solid growth in the number of residential high-speed Internet customers.
Further, expanding Wi-Fi coverage and innovative xFi control features are improving customer experience. Moreover, the company’s Xfinity Mobile is now used by more than one million customers. The company’s recent plan to sell Apple Watch 4 and iPads with LTE to Xfinity Mobile customers is expected to drive its user base.
Additionally, the Sky acquisition has expanded Comcast’s international reach. Sky’s content strength is a major growth driver. Meanwhile, estimates have been going up ahead of the company’s second-quarter earnings release. The company has recorded positive earnings surprises in last few quarters.
(You can read the full research report on Comcast here >>>).
Morgan Stanley’s shares have gained +9.2% over the past six months, outperforming the Zacks Investment Banking industry, which has increased +6% over the same period. The company has an impressive earnings surprise history, having surpassed expectations in three of the trailing four quarters.
The Zacks analyst thinks the acquisition of Solium Capital is in sync with the company’s efforts to further strengthen its wealth management business. Its focus on its corporate lending unit, steady loan growth, higher interest rates and normalized levels of trading activities will likely aid revenue growth. Further, its steady capital deployment activities indicate a strong balance sheet position (indicated by stress test clearance).
However, slowdown in debt originations will likely hinder underwriting fee income growth and hurt the company’s investment banking performance. Further, elevated operating expenses are likely to hurt profits.
(You can read the full research report on Morgan Stanley here >>>).
Other noteworthy reports we are featuring today include Micron and Ford.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Investment Research
800-767-3771 ext. 9339
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performance for information about the performance numbers displayed in this press release.